<DOC>
	<DOCNO>NCT01476020</DOCNO>
	<brief_summary>The ITALIC PLUS Trial design objective extending country enrollment patient ITALIC trial initially conduct France , order achieve statistical significance pool data trial .</brief_summary>
	<brief_title>Is There A LIfe Drug Eluting Stent ( DES ) After Discontinuation Clopidogrel</brief_title>
	<detailed_description>The use drug-eluting stent result significant reduction restenosis rate need repeat angioplasty stented lesion . However , occurrence late stent thrombosis result increase duration dual antiplatelet treatment . According guideline ESC , current recommend duration dual antiplatelet treatment 12 month . A relationship demonstrate occurrence late stent thrombosis aspirin resistance . Furthermore , dual anti-platelet treatment associate increase bleeding , severity well document . In addition , patient involve , especially 70 , significant co-morbidities often require extra-cardiac surgery easily carry patient dual antiplatelet treatment clopidogrel . The objective study determine whether , period 6 month follow Drug elute stent ( DES ) implantation patient regard sensitive aspirin , dual antiplatelet therapy may replace aspirin alone . The original Italic Trial multicenter , randomize study evaluate non-inferiority aspirin single treatment versus dual antiplatelet therapy clopidogrel aspirin 6 month drug-eluting stent implantation , include 12- , 24- 36-month follow-up analysis .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Male female subject ≥ 18 year age eligible PCI least one drug elute stent ( name : Xience ) implant clinical situation exclude primary PCI acute MI treatment leave main artery . Male female subject ≥ 18 year age eligible PCI least one DES Xience . Patient pretreated protein IIb/IIIa inhibitor ( name : abxicimab eptifibatide ) hospitalization Patient pretreated aspirin clopidogrel PCI ASA check least 24 hour interruption tirofiban The subject give write inform dated consent participate study . Subjects able give inform consent Prior implantation DES Known platelet &lt; 100 000/µl know hemorrhagic diathesis Oral anticoagulation treatment abxicimab eptifibatide hospitalization ASA check le 24 hour interruption tirofiban Thrombolytic therapy within 4 day ASA check Contraindication aspirin clopidogrel Recent major surgery &lt; 6 week Evidence active gastrointestinal urogenital bleeding Severe liver insufficiency Primary PCI acute MI Left main PCI Any schedule surgery year enrollment Severe concomitant disease life expectation &lt; two year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Drug elute stent</keyword>
	<keyword>Dual antiplatelet therapy</keyword>
	<keyword>bleeding</keyword>
	<keyword>stent thrombosis</keyword>
	<keyword>follow-up drug elute stent</keyword>
</DOC>